Executive corporate officers | Employment contract | Supplementary pension plan | Indemnities or benefits due or payable on cessation or change in functions | Indemnities under a non-compete clause |
|---|---|---|---|---|
Management Board | Management Board Employment contract
| Management Board Supplementary pension plan
| Management Board Indemnities or benefits due or payable on cessation or change in functions
| Management Board Indemnities under a non-compete clause
|
Arthur Sadoun, Chairman | Arthur Sadoun, Chairman Employment contract No | Arthur Sadoun, Chairman Supplementary pension plan No | Arthur Sadoun, Chairman Indemnities or benefits due or payable on cessation or change in functions Yes(1) | Arthur Sadoun, Chairman Indemnities under a non-compete clause Yes(1) |
First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 | First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Employment contract
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Supplementary pension plan
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Indemnities or benefits due or payable on cessation or change in functions
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Indemnities under a non-compete clause
|
Jean-Michel Etienne, until December 31, 2020 | Jean-Michel Etienne, until December 31, 2020 Employment contract Yes | Jean-Michel Etienne, until December 31, 2020 Supplementary pension plan No | Jean-Michel Etienne, until December 31, 2020 Indemnities or benefits due or payable on cessation or change in functions Yes(2) | Jean-Michel Etienne, until December 31, 2020 Indemnities under a non-compete clause No |
First appointment: July 1, 2010 Expiry of term of office: December 31, 2020 | First appointment: July 1, 2010 Expiry of term of office: December 31, 2020 Employment contract
| First appointment: July 1, 2010 Expiry of term of office: December 31, 2020 Supplementary pension plan
| First appointment: July 1, 2010 Expiry of term of office: December 31, 2020 Indemnities or benefits due or payable on cessation or change in functions
| First appointment: July 1, 2010 Expiry of term of office: December 31, 2020 Indemnities under a non-compete clause
|
Anne-Gabrielle Heilbronner | Anne-Gabrielle Heilbronner Employment contract Yes | Anne-Gabrielle Heilbronner Supplementary pension plan No | Anne-Gabrielle Heilbronner Indemnities or benefits due or payable on cessation or change in functions Yes(3) | Anne-Gabrielle Heilbronner Indemnities under a non-compete clause Yes(3) |
First appointment: September 15, 2014 Expiry of term of office: September 14, 2022 | First appointment: September 15, 2014 Expiry of term of office: September 14, 2022 Employment contract
| First appointment: September 15, 2014 Expiry of term of office: September 14, 2022 Supplementary pension plan
| First appointment: September 15, 2014 Expiry of term of office: September 14, 2022 Indemnities or benefits due or payable on cessation or change in functions
| First appointment: September 15, 2014 Expiry of term of office: September 14, 2022 Indemnities under a non-compete clause
|
Steve King | Steve King Employment contract Yes | Steve King Supplementary pension plan Yes | Steve King Indemnities or benefits due or payable on cessation or change in functions Yes(4) | Steve King Indemnities under a non-compete clause Yes(4) |
First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 | First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Employment contract
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Supplementary pension plan
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Indemnities or benefits due or payable on cessation or change in functions
| First appointment: June 1, 2017 Expiry of term of office: September 14, 2022 Indemnities under a non-compete clause
|
Michel-Alain Proch, from January 15, 2021 | Michel-Alain Proch, from January 15, 2021 Employment contract Yes | Michel-Alain Proch, from January 15, 2021 Supplementary pension plan No | Michel-Alain Proch, from January 15, 2021 Indemnities or benefits due or payable on cessation or change in functions Yes(5) | Michel-Alain Proch, from January 15, 2021 Indemnities under a non-compete clause Yes(5) |
First appointment: January 15, 2021 Expiry of term of office: September 14, 2022 | First appointment: January 15, 2021 Expiry of term of office: September 14, 2022 Employment contract
| First appointment: January 15, 2021 Expiry of term of office: September 14, 2022 Supplementary pension plan
| First appointment: January 15, 2021 Expiry of term of office: September 14, 2022 Indemnities or benefits due or payable on cessation or change in functions
| First appointment: January 15, 2021 Expiry of term of office: September 14, 2022 Indemnities under a non-compete clause
|
(1) See Section 3.2.1.5 “Compensation policy for the Chairman of the Management Board”.
(2) See Section 3.2.1.4 “Compensation policy for members of the Management Board” of the 2019 Universal Registration Document.
(3) See Section 3.2.1.6 “Compensation policy for Anne-Gabrielle Heilbronner”.
(4) See Section 3.2.1.7 “Compensation policy for Steve King”.
(5) See Section 3.2.1.8 “Compensation policy for Michel-Alain Proch”.
At December 31, 2020, no members of the Management Board and the Supervisory Board owned more than 1% of the Company’s shares, with the exception of Élisabeth Badinter and her children (6.74%), and Maurice Lévy, who owns directly or indirectly 4,764,706 shares, i.e. 1.92% of the Company’s capital, including 2,509,602 shares owned through a company belonging to Maurice Lévy and his family.
As of December 31, 2020, the members of the Management Board and the Supervisory Board (with the exception of Élisabeth Badinter and her children) directly and indirectly owned 6,881,207 shares, i.e. 2.78% of the share capital of the Company, including 1.92% controlled by Maurice Lévy.
As of December 31, 2020, the members of the Management Board also owned 90,947 stock options, all of which are exercisable. The weighted average exercise price of the options is euro 52.76 per share with these options expiring in 2023 (see note 31 to the consolidated financial statements in Section 6.6).
The following table shows the interest of each corporate officer in the share capital of the Company at December 31, 2020 by the number of shares and voting rights, as well as the number of shares that each corporate officer has the right to acquire through the exercise of new stock subscription options and existing stock purchase options.
